I calculate a post-tax DCF of $191m - $0.193 per share - over the 5 year LoM.
Add the FY2019 Net Assets of $82m to arrive at an intrinsic value of $273m - $0.275 per share.
If the project is extended beyond 5 years, then the Terminal Value plus DCF equates to an Equity Valuation of $576m - $0.581 per share.
- Forums
- ASX - By Stock
- IMA
- 168 m market cap . Buy of the century
168 m market cap . Buy of the century, page-30
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMA (ASX) to my watchlist
|
|||||
Last
7.4¢ |
Change
0.001(0.68%) |
Mkt cap ! $82.54M |
Open | High | Low | Value | Volume |
7.4¢ | 7.4¢ | 7.4¢ | $1.195K | 16.15K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 156173 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 19593 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14152 | 0.077 |
1 | 2000 | 0.074 |
3 | 156173 | 0.073 |
5 | 361822 | 0.072 |
1 | 55000 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 14742 | 1 |
0.074 | 21003 | 1 |
0.075 | 20000 | 1 |
0.078 | 49297 | 1 |
0.079 | 55889 | 2 |
Last trade - 10.04am 16/07/2024 (20 minute delay) ? |
Featured News
IMA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online